Patent directory · USPTO A61K / A61P
Patents matching “CTOR”
756 pharma patents match "CTOR" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 756 pharmaceutical patents matching "CTOR" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11028444
Survival predictor for diffuse large B cell lymphoma
granted -
US 11020458
Factor VIII polymer conjugates
granted -
US 11020459
Factor VIII formulations
granted -
US 11014980
Transforming growth factor-beta-responsive polypeptides and their methods for use
granted -
US 11007201
Corticotropin releasing factor receptor antagonists
granted -
US 10993999
Materials and methods for producing improved lentiviral vector particles
granted -
US 10988733
Methods for obtaining pluripotent adult olfactory stem cells from an olfactory mucosa tissue
granted -
US 10982203
Modified factor IX polypeptides and uses thereof
granted -
US 10982001
Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R)
granted -
US 10975153
Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R)
granted -
US 10968442
Chimeric clotting factors
granted -
US 10954530
Retroviral and lentiviral vectors
granted -
US 10934544
Factor XII (hageman factor) (F12), kallikrein B, plasma (fletcher factor) 1 (KLKB1), and kininogen 1 (KNG1) iRNA compositions and methods of use thereof
granted -
US 10927346
Enhanced immune effector cells and use thereof
granted -
US 10918738
Method of treating type I diabetes using an AAV vector encoding uracortin 2
granted -
US 10898554
Factor IX polypeptides and methods of use thereof
granted -
US 10894966
Virus-based expression vectors and uses thereof
granted -
US 10881742
Factor VIII chimeric and hybrid polypeptides, and methods of use thereof
granted -
US 10883107
Polynucleotide agents targeting factor XII (hageman factor) (F12) and methods of use thereof
granted -
US 2020384125
GENE EDITING FOR HEMOPHILIA A WITH IMPROVED FACTOR VIII EXPRESSION
granted -
US 10858658
Compositions and methods for inhibiting gene expression of factor XII
granted -
US 10849908
Corticotropin releasing factor receptor antagonists
granted -
US 10822421
Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R)
granted -
US 10813913
Small molecules that mimic or antagonize actions of granulocyte colony-stimulating-factor (G-CSF)
granted